Cancer angiogenesis: Targeting the heel of Achilles

References

• American Cancer Society. 2007. Cancer facts and figures, 1.
   Google Scholar
• Ansiaux R, Baudelet C, Jordan BF, Beghein N, Sonveaux P, De Wever J, Martinive P, Gregoire V, Feron O, Gallez B. Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. Clin Cancer Res 2005; 11(2 Pt 1)743–750
   PubMed Web of Science ®Google Scholar
• Anwer K, Bailey A, Sullivan SM. Targeted gene delivery: A two-pronged approach. Crit Rev Ther Drug Carrier Syst 2000a; 17: 377–424
   PubMed Web of Science ®Google Scholar
• Anwer K, Meaney C, Kao G, Hussain N, Shelvin R, Earls RM, Leonard P, Quezada A, Rolland AP, Sullivan SM. Cationic lipid-based delivery system for systemic cancer gene therapy. Cancer Gene Ther 2000b; 7: 1156–1164
   PubMed Web of Science ®Google Scholar
• Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancukiewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, Ivy P, Scadden DT, Benner T, Loeffler JS, Wen PY, Jain RK. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 2007; 11(1)83–95
   PubMed Web of Science ®Google Scholar
• Beckenlehner K, Bannke S, Spruss T, Bernhardt G, Schonenberg H, Schiess W. Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo. J Cancer Res Clin Oncol 1992; 118: 591–596
   PubMed Web of Science ®Google Scholar
• Benjamin LE, Keshet E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci U S A 1997; 94: 8761–8766
   PubMed Web of Science ®Google Scholar
• Brock TA, Dvorak HF, Senger DR. Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. Am J Pathol 1991; 138: 213–221
   PubMed Web of Science ®Google Scholar
• Burton MA, Gray BN, Coletti A. Effect of angiotensin II on blood flow in the transplanted sheep squamous cell carcinoma. Eur J Cancer Clin Oncol 1988; 24: 1373–1376
   PubMedGoogle Scholar
• Cady FM, Kneuper-Hall R, Metcalf JS. Histologic patterns of polyethylene glycol-liposomal doxorubicin-related cutaneous eruptions. Am J Dermatopathol 2006; 28(2)168–172
   PubMed Web of Science ®Google Scholar
• Campbell RB, Fukumura D, Brown EB, Mazzola LM, Izumi Y, Jain RK, Torchilin VP, Munn LL. Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. Cancer Res 2002; 62: 6831–6836
   PubMed Web of Science ®Google Scholar
• Chen Q-R, Kumar D, Stass SA, Mixson AJ. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice. Cancer Res 1999; 59: 3308–3312
   PubMed Web of Science ®Google Scholar
• Cheung AM, Brown AS, Cucevic V, Roy M, Needles A, Yang V, Hicklin DJ, Kerbel RS, Foster FS. Detecting vascular changes in tumour xenografts using micro-ultrasound and micro-CT following treatment with VEGFR-2 blocking antibodies. Ultrasound Med Biol 2007; 33(8)1259–1268
   PubMed Web of Science ®Google Scholar
• Dass CR, Burton MA. A model for evaluating selective delivery of plasmid DNA to tumours via the vasculature. Cancer Biother Radiopharm 2002; 17: 501–505
   PubMed Web of Science ®Google Scholar
• Dass CR, Burton MA. Modified microplex vector enhances transfection of cells in culture while maintaining tumour-selective gene delivery in vivo. J Pharm Pharmacol 2003; 55: 19–25
   PubMed Web of Science ®Google Scholar
• Dass CR, Walker TL, Kalle WH, Burton MA. A microsphere-liposome (microplex) vector for targeted gene therapy of cancer. II. In vivo biodistribution study in a solid tumor model. Drug Deliv 2000; 7(1)15–19
   PubMed Web of Science ®Google Scholar
• Dass CR, Walker TL, Burton MA. Liposomes containing cationic dimethyl dioctadecyl ammonium bromide (DDAB): Formulation, quality control and lipofection efficiency. Drug Deliv 2002; 9: 11–18
   PubMed Web of Science ®Google Scholar
• Dass CR, Tran TMN, Choong PFM. Angiogenesis inhibitors and the need for anti-angiogenic therapeutics. J Dent Res 2007a; 86: 927–936
   PubMed Web of Science ®Google Scholar
• Dass CR, Contreras KG, Dunstan DE, Choong PF. Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma. Biomaterials 2007b; 28: 3026–3033
   PubMed Web of Science ®Google Scholar
• Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis. Science 1999; 285(5425)245–248
   PubMed Web of Science ®Google Scholar
• Dellian M, Yuan F, Trubetskoy VS, Torchilin VP, Jain RK. Vascular permeability in a human tumour xenograft: Molecular charge dependence. Br J Cancer 2000; 82: 1513–1518
   PubMed Web of Science ®Google Scholar
• Dickson PV, Hamner JB, Sims TL, Fraga CH, Ng CY, Rajasekeran S, Hagedorn NL, McCarville MB, Stewart CF, Davidoff AM. Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy. Clin Cancer Res 2007; 13(13)3942–3950
   PubMed Web of Science ®Google Scholar
• Dings RP, Loren M, Heun H, McNiel E, Griffioen AW, Mayo KH, Griffin RJ. Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization. Clin Cancer Res 2007; 13(11)3395–3402
   PubMed Web of Science ®Google Scholar
• Dong Z, Zeitlin BD, Song W, Sun Q, Karl E, Spencer DM, Jain HV, Jackson T, Nunez G, Nor JE. Level of endothelial cell apoptosis required for a significant decrease in microvessel density. Exp Cell Res 2007; 313: 3645–57
   PubMed Web of Science ®Google Scholar
• Eichhorn ME, Becker S, Strieth S, Werner A, Sauer B, Teifel M, Ruhstorfer H, Michaelis U, Griebel J, Brix G, Jauch KW, Dellian M. Paclitaxel encapsulated in cationic lipid complexes (MBT-0206) impairs functional tumor vascular properties as detected by dynamic contrast enhanced magnetic resonance imaging. Cancer Biol Ther 2006; 5(1)89–96
   PubMed Web of Science ®Google Scholar
• Eichhorn ME, Luedemann S, Strieth S, Papyan A, Ruhstorfer H, Haas H, Michaelis U, Sauer B, Teifel M, Enders G, Brix G, Jauch KW, Bruns CJ, Dellian M. Cationic lipid complexed camptothecin (EndoTAG((R))-2) improves antitumoral efficacy by tumor vascular targeting. Cancer Biol Ther 2007; 6(6)920–929
   PubMed Web of Science ®Google Scholar
• Ek ET, Dass CR, Contreras KG, Choong PF. Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor. Clin Exp Mets 2007a; 24: 93–106
   PubMed Web of Science ®Google Scholar
• Ek ET, Dass CR, Contreras KG, Choong PF. Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis. Cancer Gene Ther 2007b; 14: 616–626
   PubMed Web of Science ®Google Scholar
• Ferrara N, Hillan KJ, Gerber HP, Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 2004; 3: 391–400
   PubMed Web of Science ®Google Scholar
• Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med 1971; 285: 1182–1186
   PubMed Web of Science ®Google Scholar
• Folkman J, Cotran R. Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 1976; 16: 207–248
   PubMedGoogle Scholar
• Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442–447
   PubMed Web of Science ®Google Scholar
• Fukumura D, Yuan F, Endo M, Jain RK. Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability and leukocyte–endothelial interactions. Am J Pathol 1997; 150: 713–725
   PubMed Web of Science ®Google Scholar
• Ganss R. Tumor stroma fosters neovascularization by recruitment of progenitor cells into the tumor bed. J Cell Mol Med 2006; 10(4)857–865
   PubMed Web of Science ®Google Scholar
• Handsley MM, Edwards DR. Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer 2005; 115(6)849–860
   PubMed Web of Science ®Google Scholar
• Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald DM. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000; 156: 1363–1380
   PubMed Web of Science ®Google Scholar
• Hobarth K, Maier U, Marberger M. Topical chemoprophylaxis of superficial bladder cancer with mitomycin C and adjuvant hyaluronidase. Eur Urol 1992; 21: 206–210
   PubMed Web of Science ®Google Scholar
• Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc Natl Acad Sci U S A 1998; 95: 4607–4612
   PubMed Web of Science ®Google Scholar
• Jain RK. Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev 2001; 46: 149–168
   PubMed Web of Science ®Google Scholar
• Jakowlew SB. Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev 2006; 25(3)435–457
   PubMed Web of Science ®Google Scholar
• Johnston SR, Gore ME. Caelyx: Phase II studies in ovarian cancer. Eur J Cancer 2001; 37: S8–14
   Web of Science ®Google Scholar
• Juliano RL. The role of β1 integrins in tumors. Semin Cancer Biol 1993; 4: 277–283
   PubMed Web of Science ®Google Scholar
• Kamat AA, Kim TJ, Landen CN, Jr., Lu C, Han LY, Lin YG, Merritt WM, Thaker PH, Gershenson DM, Bischoff FZ, Heymach JV, Jaffe RB, Coleman RL, Sood AK. Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer. Cancer Res 2007; 67(1)281–288
   PubMed Web of Science ®Google Scholar
• Klimuk SK, Semple SC, Nahirney PN, Mullen MC, Bennett CF, Scherrer P, Hope MJ. Enhanced anti-inflammatory activity of a liposomal intercellular adhesion molecule-1 antisense oligodeoxynucleotide in an acute model of contact hypersensitivity. J Pharmacol Exp Ther 2000; 292: 480–488
   PubMed Web of Science ®Google Scholar
• Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size. Cancer Res 2000; 60: 4440–4445
   PubMed Web of Science ®Google Scholar
• Kong G, Braun RD, Dewhirst MW. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res 2001; 61: 3027–3032
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Koukouraki S, Fezoulidis I, Kelekis N, Kyrias G, Archimandritis S, Karkavitsas N. High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours. Br J Cancer 2000; 83: 1281–1286
   PubMed Web of Science ®Google Scholar
• Kristensen CA, Roberge S, Jain RK. Effect of tumor necrosis factor alpha on vascular resistance, nitric oxide production and glucose and oxygen consumption in perfused tissue-isolated human melanoma xenografts. Clin Cancer Res 1997; 3: 319–324
   PubMed Web of Science ®Google Scholar
• Kunstfeld R, Wickenhauser G, Michaelis U, Teifel M, Umek W, Naujoks K, Wolff K, Petzelbauer P. Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a “humanized” SCID mouse model. J Invest Dermatol 2003; 120: 476–482
   PubMed Web of Science ®Google Scholar
• Leonetti C, Biroccio A, Benassi B, Stringaro A, Stoppacciaro A, Semple SC, Zupi G. Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line. Cancer Gene Ther 2001; 8: 459–468
   PubMed Web of Science ®Google Scholar
• Liu F, Qi H, Huang L, Liu D. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Ther 1997; 4: 517–523
   PubMed Web of Science ®Google Scholar
• Lu J, Jackson JK, Gleave ME, Burt HM. The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors. Cancer Chemother Pharmacol 2007, Aug 15; [Epub ahead of print]
   Web of Science ®Google Scholar
• Mancuso MR, Davis R, Norberg SM, O'Brien S, Sennino B, Nakahara T, Yao VJ, Inai T, Brooks P, Freimark B, Shalinsky DR, Hu-Lowe DD, McDonald DM. Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J Clin Invest 2006; 116(10)2610–2621
   PubMed Web of Science ®Google Scholar
• Michel CC. Capillary permeability and how it may change. J Physiol 1988; 404: 1–29
   PubMed Web of Science ®Google Scholar
• Miller DW, Vosseler S, Mirancea N, Hicklin DJ, Bohlen P, Volcker HE, Holz FG, Fusenig NE. Rapid vessel regression, protease inhibition, and stromal normalization upon short-term vascular endothelial growth factor receptor 2 inhibition in skin carcinoma heterotransplants. Am J Pathol 2005; 167(5)1389–1403
   PubMed Web of Science ®Google Scholar
• Mui B, Raney SG, Semple SC, Hope MJ. Immune stimulation by a CpG-containing oligodeoxynucleotide in enhanced when encapsulated and delivered in lipid particles. J Pharmacol Exp Ther 2001; 298: 1185–1192
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay D, Nagy JA, Manseau EJ, Dvorak HF. Vascular permeability factor/vascular endothelial derived growth factor mediated signaling in mouse mesentary vascular endothelium. Cancer Res 1998; 58: 1278–1284
   PubMed Web of Science ®Google Scholar
• Nakahara T, Norberg SM, Shalinsky DR, Hu-Lowe DD, McDonald DM. Effect of inhibition of vascular endothelial growth factor signaling on distribution of extravasated antibodies in tumors. Cancer Res 2006; 66(3)1434–1445
   PubMed Web of Science ®Google Scholar
• Netti PA, Berk DA, Swartz MA, Grodzinsky AJ, Jain RK. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res 2000; 60: 2497–2503
   PubMed Web of Science ®Google Scholar
• Nishi T, Yoshizato K, Yamashiro S, Takeshima H, Sato K, Hamada K, Kitamura I, Yoshimura T, Saya H, Kuratsu J, Ushio Y. High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. Cancer Res 1996; 56: 1050–1055
   PubMed Web of Science ®Google Scholar
• Patan S, Munn LL, Jain RK. Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: A novel mechanism of tumor angiogenesis. Microvasc Res 1996; 51: 260–272
   PubMed Web of Science ®Google Scholar
• Rainov NG, Ikeda K, Qureshi NH, Grover S, Herrlinger U, Pechan P, Chiocca EA, Breakefield XO, Barnett FH. Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasms. Hum Gene Ther 1999; 10: 311–318
   PubMed Web of Science ®Google Scholar
• Ruoslahti E, Reed JC. Anchorage dependence, integrins and apoptosis. Cell 1994; 77: 477–478
   PubMed Web of Science ®Google Scholar
• Sangai T, Ishii G, Kodama K, Miyamoto S, Aoyagi Y, Ito T, Magae J, Sasaki H, Nagashima T, Miyazaki M, Ochiai A. Effect of differences in cancer cells and tumor growth sites on recruiting bone marrow-derived endothelial cells and myofibroblasts in cancer-induced stroma. Int J Cancer 2005; 115(6)885–892
   PubMed Web of Science ®Google Scholar
• Schmid RM, Weidenbach H, Yamagushi H, Luhrs H, Liptay S, Adler G. Direct gene transfer into the rat pancreas using DNA-liposomes. Eur J Clin Invest 1998; 28: 220–226
   PubMed Web of Science ®Google Scholar
• Sevick EM, Jain RK. Effect of red blood cell rigidity on tumor blood flow: Increase in viscous resistance during hyperglycemia. Cancer Res 1991; 51: 2727–2730
   PubMed Web of Science ®Google Scholar
• Stearne LE, Schifferlers RM, Smouter E, Bakker-Woudenberg IA, Gussens IC. Biodistribution of long-circulating PEG-liposomes in a murine model of established subcutaneous abscesses. Biochim Biophys Acta 2002; 1561: 91–97
   PubMed Web of Science ®Google Scholar
• Tabruyn SP, Griffioen AW. Molecular pathways of angiogenesis inhibition. Biochem Biophys Res Commun 2007; 355(1)1–5
   PubMed Web of Science ®Google Scholar
• Thurston G, McLean JW, Rizen M, Baluk P, Haskell A, Murphy TJ, Hanahan D, McDonald DM. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J Clin Invest 1998; 101: 1401–1413
   PubMed Web of Science ®Google Scholar
• Tong RT, Boucher Y, Kozin SV, Winkler F, Hicklin DJ, Jain RK. Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res 2004; 64(11)3731–3736
   PubMed Web of Science ®Google Scholar
• Tsafnat N, Tsafnat G, Lambert TD, Jones SK. Modelling heating of liver tumours with heterogeneous magnetic microsphere deposition. Phys Med Biol 2005; 50(12)2937–2953
   PubMed Web of Science ®Google Scholar
• Vosseler S, Mirancea N, Bohlen P, Mueller MM, Fusenig NE. Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants. Cancer Res 2005; 65(4)1294–1305
   PubMed Web of Science ®Google Scholar
• Weinbaum S, Cowin SC, Zeng Y. A model for the excitation of osteocytes by mechanical loading-induced bone fluid shear stresses. J Biomech 1994; 27: 339–360
   PubMed Web of Science ®Google Scholar
• Yasui N, Mori T, Morito D, Matsushita O, Kourai H, Nagata K, Koide T. Dual-site recognition of different extracellular matrix components by anti-angiogenic/neurotrophic serpin, PEDF. Biochemistry 2003; 42(11)3160–3167
   PubMed Web of Science ®Google Scholar
• Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H, Kuwano M. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 1997; 17(7)4015–4023
   PubMed Web of Science ®Google Scholar